Literature DB >> 6279342

The isolation of the antibody moieties of immune complexes from serum by the pepsin digestion of conglutinin-anti-conglutinin complexes.

P J Lachmann, M Macanovic, G D Harkiss, R G Oldroyd, J Habicht.   

Abstract

A technique is described which allows the antibodies of circulating immune complexes to be isolated as their F(ab')2 fragments. The method is based on the precipitation of the complexes by the sequential addition of conglutinin and anti-conglutinin, and the subsequent digestion of these precipitates by pepsin. Using this technique it has been possible to show antibodies to Epstein-Barr (EB) virus antigens in the immune complexes of patients with Burkitt's lymphoma and to microbial antigens in two patients with nephritis. By substituting DNAase for pepsin it has also been possible to show antibodies to DNA-containing nuclear antigens in the serum of patients with systemic lupus erythematosus.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6279342      PMCID: PMC1536397     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  5 in total

1.  A comparison of some properties of bovine conglutinin with those of rabbit immuno-conglutinin.

Authors:  P J LACHMANN
Journal:  Immunology       Date:  1962-11       Impact factor: 7.397

2.  Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells.

Authors:  I McConnell; G Klein; T F Lint; P J Lachmann
Journal:  Eur J Immunol       Date:  1978-07       Impact factor: 5.532

3.  The purification of specific antibody as F(ab')2 by the pepsin digestion of antigen-antibody precipitates, and its application to immunoglobulin and complement antigens.

Authors:  P J Lachmann
Journal:  Immunochemistry       Date:  1971-01

4.  Conglutinin binding polyethylene glycol precipitation assay for immune complexes.

Authors:  M Macanovic; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

5.  Purification of soluble immune complexes from serum using polymethylmetacrylate beads coated with conglutinin or C1q. Application to the analysis of the components of in vitro formed immune complexes and of immune complexes occurring in vivo during leishmaniasis.

Authors:  P Casali; P H Lambert
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

  5 in total
  5 in total

1.  An efficient one-step method for isolating immune complexes from whole serum using a monoclonal anti-C3g affinity immunosorbent.

Authors:  D J Samuel; P L Amlot; P Shepherd; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

2.  Antibody moieties within circulating immune complexes in heart transplant recipients.

Authors:  G D Harkiss; D L Brown; D J Smith; J Nagington
Journal:  Clin Exp Immunol       Date:  1983-01       Impact factor: 4.330

3.  Recovery of a cell surface fetal antigen from circulating immune complexes of melanoma patients.

Authors:  J H Wong; B Aguero; R K Gupta; D L Morton
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

4.  Evidence for a disease specific antigen in circulating immune complexes in ankylosing spondylitis.

Authors:  C Bruneau; H Bonin
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

5.  Characterization of antigen moiety of HBsAg in the complement fixing immune complexes of hepatitis B virus positive chronic active hepatitis.

Authors:  R C Gupta
Journal:  Clin Exp Immunol       Date:  1982-09       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.